Bullboard - Stock Discussion Forum Insmed Inc INSM

Healthcare Biotechnology

Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs... see more

Add To Watchlist

NDAQ:INSM - Post Discussion

Insmed Inc > INSM Price Target Alert: $74.00. Issued by Goldman Sachs

View:

Post by whytestocks on May 28, 2024 4:15pm

INSM Price Target Alert: $74.00. Issued by Goldman Sachs

BREAKING NEWS: $INSM INSM Price Target Alert: $74.00. Issued by Goldman Sachs2024-05-28 16:00:07 ET Andrea Tan from Goldman Sachs issued a price target of $74.00 for INSM on 2024-05-28 13:27:00. The adjusted price target was set to $74.00. At the time of the announcement, INSM was trading at $46.39. The overall price target consensus is at $46.67...INSM - INSM Price Target Alert: $74.00. Issued by Goldman Sachs